ALTSHULER DAVID 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 26, 2025
Insider Transaction Report
Form 4
ALTSHULER DAVID
EVP, Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2025-02-24$483.28/sh−3,971$1,919,105→ 41,048 total - Sale
Common Stock
2025-02-25$480.95/sh−848$407,846→ 40,200 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024.